Advertisement

Picture Berlin Partner German Biotech Days 2024 in Berlin 650x100px
Document › Details

Pieris Pharmaceuticals, Inc.. (8/9/18). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA.

Organisations Organisation Pieris Pharmaceuticals Inc. (Nasdaq: PIRS)
  Group Pieris (Group)
  Organisation 2 AstraZeneca plc (LSE: AZN)
  Group AstraZeneca (Group)
Products Product cinrebafusp alfa (PRS-343)
  Product 2 elarekibep (PRS-060/AZD1402, anti-IL4Ra Anticalin, Pieris/AstraZeneca)
Person Person Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP)
     


   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Pieris (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px




» top